Matthew Goff Investment Advisor’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Sell
115,209
-1,490
-1% -$174K 2.5% 13
2026
Q1
$14M Buy
116,699
+332
+0.3% +$38.3K 2.34% 11
2025
Q4
$12.2M Sell
116,367
-1,728
-1% -$162K 2.17% 13
2025
Q3
$9.91M Sell
118,095
-901
-0.8% -$74.2K 1.69% 19
2025
Q2
$9.42M Sell
118,996
-368
-0.3% -$29.3K 1.74% 19
2025
Q1
$10.7M Buy
119,364
+2,860
+2% +$267K 1.98% 16
2024
Q4
$11.6M Buy
116,504
+220
+0.2% +$22.7K 2.15% 14
2024
Q3
$13.2M Sell
116,284
-43
-0% -$5.11K 2.51% 13
2024
Q2
$14.4M Sell
116,327
-790
-0.7% -$102K 2.94% 10
2024
Q1
$15.5M Sell
117,117
-1,842
-2% -$227K 3.13% 10
2023
Q4
$13M Sell
118,959
-987
-0.8% -$102K 2.88% 12
2023
Q3
$12.3M Sell
119,946
-982
-0.8% -$106K 2.97% 10
2023
Q2
$14M Sell
120,928
-3,476
-3% -$395K 3.28% 8
2023
Q1
$13.2M Sell
124,404
-2,604
-2% -$281K 3.28% 7
2022
Q4
$14.1M Sell
127,008
-535
-0.4% -$54.7K 3.67% 7
2022
Q3
$11M Buy
127,543
+1,442
+1% +$129K 3.14% 9
2022
Q2
$11.5M Buy
126,101
+10,280
+9% +$911K 3.1% 11
2022
Q1
$9.5M Buy
115,821
+12,581
+12% +$992K 2.23% 16
2021
Q4
$7.91M Sell
103,240
-111
-0.1% -$8.84K 1.81% 20
2021
Q3
$7.76M Buy
103,351
+3,200
+3% +$243K 1.9% 18
2021
Q2
$7.79M Buy
100,151
+1,635
+2% +$122K 1.98% 19
2021
Q1
$7.25M Buy
98,516
+40
+0% +$2.95K 2.04% 19
2020
Q4
$7.69M Buy
98,476
+5,561
+6% +$425K 2.29% 16
2020
Q3
$7.35M Sell
92,915
-409
-0.4% -$32K 2.35% 17
2020
Q2
$6.89M Buy
93,324
+611
+0.7% +$46K 2.26% 14
2020
Q1
$6.81M Buy
92,713
+3,103
+3% +$244K 2.87% 10
2019
Q4
$7.78M Sell
89,610
-2,089
-2% -$172K 2.88% 12
2019
Q3
$7.37M Sell
91,699
-2,060
-2% -$165K 3.04% 10
2019
Q2
$7.5M Sell
93,759
-646
-0.7% -$49.5K 3.21% 10
2019
Q1
$7.49M Buy
94,405
+194
+0.2% +$14.5K 3.46% 8
2018
Q4
$6.87M Buy
94,211
+558
+0.6% +$39.4K 3.49% 10
2018
Q3
$6.34M Buy
93,653
+947
+1% +$60.3K 2.54% 15
2018
Q2
$5.37M Buy
92,706
+7,452
+9% +$420K 2.1% 19
2018
Q1
$4.43M Buy
85,254
+2,764
+3% +$149K 1.86% 23
2017
Q4
$4.43M Buy
82,490
+192
+0.2% +$10.6K 1.91% 23
2017
Q3
$5.03M Buy
82,298
+2,286
+3% +$139K 2.16% 19
2017
Q2
$4.89M Sell
80,012
-625
-0.8% -$38K 4.39% 7
2017
Q1
$4.89M Buy
+80,637
New +$4.89M 4.67% 7

Other funds holding MRK

Matthew Goff Investment Advisor's MRK Position: Q2 2026 in Review

Matthew Goff Investment Advisor reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $174K and leaving 115,209 shares worth $14.8M. The position accounts for 2.5% of the portfolio, ranked #13.

Matthew Goff Investment Advisor first reported a position in MRK in Q1 2017 and has held it in 38 quarters since. The position peaked at $15.5M in Q1 2024. 966 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Matthew Goff Investment Advisor held 115,209 shares of Merck worth $14.8M as of Q2 2026.
  • Matthew Goff Investment Advisor sold 1,490 Merck shares in Q2 2026, an estimated $174K.
  • Merck made up 2.5% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #13 holding.
  • Matthew Goff Investment Advisor first reported a position in Merck in Q1 2017 and has held it in 38 quarters since.
  • Matthew Goff Investment Advisor's Merck position peaked at $15.5M in Q1 2024.
  • 966 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.